{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:03:52Z","timestamp":1789369432031,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T00:00:00Z","timestamp":1100217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T00:00:00Z","timestamp":1100217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Dupuytren's disease (DD) is a debilitating fibro-proliferative disorder of the hand characterized by the appearance of fibrotic lesions (nodules and cords) leading to flexion contractures of the fingers and loss of hand function. Although the molecular mechanism of DD is unknown, it has been suggested that transforming growth factor-\u03b2<jats:sub>2<\/jats:sub> (TGF-\u03b2<jats:sub>2<\/jats:sub>) may play an important role in the underlying patho-physiology of the disease. The purpose of this study was to further explore this hypothesis by examining the effects of TGF-\u03b2<jats:sub>2<\/jats:sub> on primary cell cultures derived from patient-matched disease and normal palmar fascia tissue using a three-dimensional collagen contraction assay.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Fibroblast-populated collagen lattice (FPCL) contraction assays using primary cell cultures derived from diseased and control fascia of the same DD patients were studied in response to exogenous TGF-\u03b2<jats:sub>2<\/jats:sub> and neutralizing anti-TGF-\u03b2<jats:sub>2<\/jats:sub> antibodies.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Contraction of the FPCLs occurred significantly faster and to a greater extent in disease cells compared to control cells. The addition of TGF-\u03b2<jats:sub>2<\/jats:sub> enhanced the rate and degree of collagen contraction in a dose-dependent fashion for both control and diseased cells. Neutralizing anti-TGF-\u03b2<jats:sub>2<\/jats:sub> antibodies abolished exogenous TGF-\u03b2<jats:sub>2<\/jats:sub> stimulated collagen contraction, but did not inhibit the enhanced basal collagen contraction activity of disease FPCL cultures.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Although exogenous TGF-\u03b2<jats:sub>2<\/jats:sub> stimulated both disease and control FPCL contraction, neutralizing anti-TGF-\u03b2<jats:sub>2<\/jats:sub> antibodies did not affect the elevated basal collagen contraction activity of disease FPCLs, suggesting that the differences in the collagen contraction activity of control and disease FPCL cultures are not due to differences in the levels of endogenous TGF-\u03b2<jats:sub>2<\/jats:sub> activity.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2474-5-41","type":"journal-article","created":{"date-parts":[[2004,11,16]],"date-time":"2004-11-16T07:24:20Z","timestamp":1100589860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-\u03b22"],"prefix":"10.1186","volume":"5","author":[{"given":"Raymond","family":"Tse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing Siang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,11,12]]},"reference":[{"key":"105_CR1","first-page":"222","volume":"2","author":"G Dupuytren","year":"1834","unstructured":"Dupuytren G: Permanent retraction of the fingers, produced by an affection of the palmar fascia. Lancet. 1834, 2: 222-225.","journal-title":"Lancet"},{"key":"105_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0749-0712(21)00440-6","volume":"15","author":"P Burge","year":"1999","unstructured":"Burge P: Genetics of Dupuytren's disease. Hand Clin. 1999, 15: 63-71.","journal-title":"Hand Clin"},{"key":"105_CR3","first-page":"131","volume":"66","author":"G Gabbiani","year":"1972","unstructured":"Gabbiani G, Majno G: Dupuytren's contracture: fibroblast contraction? An ultrastructural study. Am J Pathol. 1972, 66: 131-146.","journal-title":"Am J Pathol"},{"key":"105_CR4","first-page":"499","volume":"53","author":"AJ Bailey","year":"1977","unstructured":"Bailey AJ, Sims TJ, Gabbiani G, Bazin S, LeLous M: Collagen of Dupuytren's disease. Clin Sci Mol Med. 1977, 53: 499-502.","journal-title":"Clin Sci Mol Med"},{"key":"105_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0072-968X(79)80045-5","volume":"11","author":"EJ Menzel","year":"1979","unstructured":"Menzel EJ, Piza H, Zielinski C, Endler AT, Steffen C, Millesi H: Collagen types and anticollagen-antibodies in Dupuytren's disease. Hand. 1979, 11: 243-248.","journal-title":"Hand"},{"key":"105_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2362.1980.tb00317.x","volume":"10","author":"S Bazin","year":"1980","unstructured":"Bazin S, Le Lous M, Duance VC, Sims TJ, Bailey AJ, Gabbiani G, D'Andiran G, Pizzolato G, Browski A, Nicoletis C, Delaunay A: Biochemistry and histology of the connective tissue of Dupuytren's disease lesions. Eur J Clin Invest. 1980, 10: 9-16.","journal-title":"Eur J Clin Invest"},{"key":"105_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2106\/00004623-198062030-00012","volume":"62","author":"RH Gelberman","year":"1980","unstructured":"Gelberman RH, Amiel D, Rudolph RM, Vance RM: Dupuytren's contracture. An electron microscopic, biochemical, and clinical correlative study. J Bone Joint Surg Am. 1980, 62: 425-432.","journal-title":"J Bone Joint Surg Am"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2106\/00004623-198163050-00014","volume":"63","author":"D Brickley-Parsons","year":"1981","unstructured":"Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP: Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg [Am]. 1981, 63: 787-797.","journal-title":"J Bone Joint Surg [Am]"},{"key":"105_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0363-5023(86)80143-5","volume":"11","author":"JJ Tomasek","year":"1986","unstructured":"Tomasek JJ, Schultz RJ, Episalla CW, Newman SA: The cytoskeleton and extracellular matrix of the Dupuytren's disease \"myofibroblast\": an immunofluorescence study of a nonmuscle cell type. J Hand Surg [Am]. 1986, 11: 365-371.","journal-title":"J Hand Surg [Am]"},{"key":"105_CR10","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2106\/00004623-198769090-00013","volume":"69","author":"JJ Tomasek","year":"1987","unstructured":"Tomasek JJ, Schultz RJ, Haaksma CJ: Extracellular matrix-cytoskeletal connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease. J Bone Joint Surg [Am]. 1987, 69: 1400-1407.","journal-title":"J Bone Joint Surg [Am]"},{"key":"105_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ar.1092300205","volume":"230","author":"JJ Tomasek","year":"1991","unstructured":"Tomasek JJ, Haaksma CJ: Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue. Anat Rec. 1991, 230: 175-182.","journal-title":"Anat Rec"},{"key":"105_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000163879","volume":"62","author":"A Berndt","year":"1994","unstructured":"Berndt A, Kosmehl H, Katenkamp D, Tauchmann V: Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology. 1994, 62: 55-58.","journal-title":"Pathobiology"},{"key":"105_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0363-5023(94)90057-4","volume":"19","author":"NL Halliday","year":"1994","unstructured":"Halliday NL, Rayan GM, Zardi L, Tomasek JJ: Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease. J Hand Surg [Am]. 1994, 19: 428-434.","journal-title":"J Hand Surg [Am]"},{"key":"105_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0065-1281(11)80184-4","volume":"97","author":"G Magro","year":"1995","unstructured":"Magro G, Lanzafame S, Micali G: Co-ordinate expression of alpha 5 beta 1 integrin and fibronectin in Dupuytren's disease. Acta Histochem. 1995, 97: 229-233.","journal-title":"Acta Histochem"},{"key":"105_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jcp.46.5.425","volume":"46","author":"KS Baird","year":"1993","unstructured":"Baird KS, Crossan JF, Ralston SH: Abnormal growth factor and cytokine expression in Dupuytren's contracture. J Clin Pathol. 1993, 46: 425-428.","journal-title":"J Clin Pathol"},{"key":"105_CR16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/BF02389692","volume":"27","author":"A Berndt","year":"1995","unstructured":"Berndt A, Kosmehl H, Mandel U, Gabler U, Luo X, Celeda D, Zardi L, Katenkamp D: TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J. 1995, 27: 1014-1020. 10.1007\/BF00175577.","journal-title":"Histochem J"},{"key":"105_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0363-5023(94)90058-2","volume":"19","author":"RL Zamora","year":"1994","unstructured":"Zamora RL, Heights R, Kraemer BA, Erlich HP, Groner JP: Presence of growth factors in palmar and plantar fibromatoses. J Hand Surg [Am]. 1994, 19: 435-441.","journal-title":"J Hand Surg [Am]"},{"key":"105_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","volume":"21","author":"MA Badalamente","year":"1996","unstructured":"Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K: The role of transforming growth factor beta in Dupuytren's disease. J Hand Surg [Am]. 1996, 21: 210-215.","journal-title":"J Hand Surg [Am]"},{"key":"105_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0363-5023(05)80067-X","volume":"20","author":"P Kloen","year":"1995","unstructured":"Kloen P, Jennings CL, Gebhardt MC, Springfield DS, Mankin HJ: Transforming growth factor-beta: possible roles in Dupuytren's contracture. J Hand Surg [Am]. 1995, 20: 101-108.","journal-title":"J Hand Surg [Am]"},{"key":"105_CR20","first-page":"443","volume":"2","author":"MA Kuhn","year":"2001","unstructured":"Kuhn MA, Payne WG, Kierney PC, Pu LL, Smith PD, Siegler K, Ko F, Wang X, Robson MC: Cytokine manipulation of explanted Dupuytren's affected human palmar fascia. Int J Surg Investig. 2001, 2: 443-456.","journal-title":"Int J Surg Investig"},{"key":"105_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1006\/excr.2000.4869","volume":"257","author":"MB Vaughan","year":"2000","unstructured":"Vaughan MB, Howard EW, Tomasek JJ: Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res. 2000, 257: 180-189. 10.1006\/excr.2000.4869.","journal-title":"Exp Cell Res"},{"key":"105_CR22","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1038\/sj.onc.1206415","volume":"22","author":"VM Varallo","year":"2003","unstructured":"Varallo VM, Gan BS, Seney S, Ross DC, Roth JH, Richards RS, McFarlane RM, Alman B, Howard JC: Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro. Oncogene. 2003, 22: 3680-3684. 10.1038\/sj.onc.1206415.","journal-title":"Oncogene"},{"key":"105_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2474-4-16","volume":"4","author":"JC Howard","year":"2003","unstructured":"Howard JC, Varallo VM, Ross DC, Roth JH, Faber KJ, Alman B, Gan BS: Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro. BMC Musculoskelet Disord. 2003, 4: 16-10.1186\/1471-2474-4-16.","journal-title":"BMC Musculoskelet Disord"},{"key":"105_CR24","doi-asserted-by":"publisher","first-page":"232\u2013238","DOI":"10.1016\/j.jss.2004.01.013","volume":"117","author":"JC Howard","year":"2004","unstructured":"Howard JC, Varallo VM, Ross DC, Faber KJ, Roth JH, Seney S, Gan BS: Elevated expression of wound healing associated proteins Hsp-47 and fibronectin in Dupuytren's contracture. J Surg Res. 2004, 117: 232\u2013238-10.1016\/j.jss.2004.01.013.","journal-title":"J Surg Res"},{"key":"105_CR25","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1073\/pnas.85.13.4894","volume":"85","author":"R Montesano","year":"1988","unstructured":"Montesano R, Orci L: Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. Proc Natl Acad Sci U S A. 1988, 85: 4894-4897.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"105_CR26","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0014-4827(90)90197-I","volume":"190","author":"H Fukamizu","year":"1990","unstructured":"Fukamizu H, Grinnell F: Spatial organization of extracellular matrix and fibroblast activity: effects of serum, transforming growth factor beta, and fibronectin. Exp Cell Res. 1990, 190: 276-282.","journal-title":"Exp Cell Res"},{"key":"105_CR27","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/S0021-9258(17)35666-1","volume":"261","author":"RA Ignotz","year":"1986","unstructured":"Ignotz RA, Massague J: Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986, 261: 4337-4345.","journal-title":"J Biol Chem"},{"key":"105_CR28","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1016\/S0021-9258(18)48258-0","volume":"262","author":"RA Ignotz","year":"1987","unstructured":"Ignotz RA, Endo T, Massague J: Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem. 1987, 262: 6443-6446.","journal-title":"J Biol Chem"},{"key":"105_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/jcp.1068","volume":"187","author":"H Wang","year":"2001","unstructured":"Wang H, Chakrabarty S: Requirement of protein kinase Calpha, extracellular matrix remodeling, and cell-matrix interaction for transforming growth factorbeta- regulated expression of E-cadherin and catenins. J Cell Physiol. 2001, 187: 188-195. 10.1002\/jcp.1068.","journal-title":"J Cell Physiol"},{"key":"105_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.yexcr.2003.09.029","volume":"293","author":"SS Cheon","year":"2004","unstructured":"Cheon SS, Nadesan P, Poon R, Alman BA: Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res. 2004, 293: 267-274. 10.1016\/j.yexcr.2003.09.029.","journal-title":"Exp Cell Res"},{"key":"105_CR31","unstructured":"ScionCorporation: http:\/\/www.scioncorp.com."},{"key":"105_CR32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3727\/095535491820873191","volume":"3","author":"AH Cory","year":"1991","unstructured":"Cory AH, Owen TC, Barltrop JA, Cory JG: Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture. Cancer Commun. 1991, 3: 207-212.","journal-title":"Cancer Commun"},{"key":"105_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1006\/abbi.1993.1311","volume":"303","author":"MV Berridge","year":"1993","unstructured":"Berridge MV, Tan AS: Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys. 1993, 303: 474-482. 10.1006\/abbi.1993.1311.","journal-title":"Arch Biochem Biophys"},{"key":"105_CR34","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994, 331: 1286-1292. 10.1056\/NEJM199411103311907.","journal-title":"N Engl J Med"},{"key":"105_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/jsre.2001.6350","volume":"103","author":"MA Kuhn","year":"2002","unstructured":"Kuhn MA, Wang X, Payne WG, Ko F, Robson MC: Tamoxifen Decreases Fibroblast Function and Downregulates TGF(beta2) in Dupuytren's Affected Palmar Fascia. J Surg Res. 2002, 103: 146-152. 10.1006\/jsre.2001.6350.","journal-title":"J Surg Res"},{"key":"105_CR36","first-page":"S31","volume":"83-A Suppl 1","author":"A Letamendia","year":"2001","unstructured":"Letamendia A, Labbe E, Attisano L: Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am. 2001, 83-A Suppl 1: S31-9.","journal-title":"J Bone Joint Surg Am"},{"key":"105_CR37","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1128\/MCB.21.15.5132-5141.2001","volume":"21","author":"M Furuhashi","year":"2001","unstructured":"Furuhashi M, Yagi K, Yamamoto H, Furukawa Y, Shimada S, Nakamura Y, Kikuchi A, Miyazono K, Kato M: Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol Cell Biol. 2001, 21: 5132-5141. 10.1128\/MCB.21.15.5132-5141.2001.","journal-title":"Mol Cell Biol"},{"key":"105_CR38","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/S0002-9440(10)61109-1","volume":"160","author":"YC Tian","year":"2002","unstructured":"Tian YC, Phillips AO: Interaction between the transforming growth factor-beta type II receptor\/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am J Pathol. 2002, 160: 1619-1628.","journal-title":"Am J Pathol"},{"key":"105_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-4827(77)80002-5","volume":"108","author":"EL Schneider","year":"1977","unstructured":"Schneider EL, Mitsui Y, Au KS, Shorr SS: Tissue-specific differences in cultured human diploid fibroblasts. Exp Cell Res. 1977, 108: 1-6.","journal-title":"Exp Cell Res"},{"key":"105_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1126\/science.6691142","volume":"223","author":"S Bordin","year":"1984","unstructured":"Bordin S, Page RC, Narayanan AS: Heterogeneity of normal human diploid fibroblasts: isolation and characterization of one phenotype. Science. 1984, 223: 171-173.","journal-title":"Science"},{"key":"105_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1242\/jcs.01005","volume":"117","author":"JM Sorrell","year":"2004","unstructured":"Sorrell JM, Caplan AI: Fibroblast heterogeneity: more than skin deep. J Cell Sci. 2004, 117: 667-675. 10.1242\/jcs.01005.","journal-title":"J Cell Sci"},{"key":"105_CR42","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S0002-9440(10)63488-8","volume":"163","author":"L Koumas","year":"2003","unstructured":"Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP: Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol. 2003, 163: 1291-1300.","journal-title":"Am J Pathol"},{"key":"105_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-5945-2-13","volume":"2","author":"CC Chipev","year":"2002","unstructured":"Chipev CC, Simon M: Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1. BMC Dermatol. 2002, 2: 13-10.1186\/1471-5945-2-13.","journal-title":"BMC Dermatol"},{"key":"105_CR44","first-page":"179","volume":"43","author":"TY Lee","year":"1999","unstructured":"Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT: Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg. 1999, 43: 179-184.","journal-title":"Ann Plast Surg"},{"key":"105_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00006534-200108000-00022","volume":"108","author":"GS Chin","year":"2001","unstructured":"Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M, Longaker MT: Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg. 2001, 108: 423-429. 10.1097\/00006534-200108000-00022.","journal-title":"Plast Reconstr Surg"},{"key":"105_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/jsre.1999.5757","volume":"87","author":"X Wang","year":"1999","unstructured":"Wang X, Smith P, Pu LL, Kim YJ, Ko F, Robson MC: Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res. 1999, 87: 194-200. 10.1006\/jsre.1999.5757.","journal-title":"J Surg Res"},{"key":"105_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1006\/jsre.1999.5580","volume":"82","author":"P Smith","year":"1999","unstructured":"Smith P, Mosiello G, Deluca L, Ko F, Maggi S, Robson MC: TGF-beta2 activates proliferative scar fibroblasts. J Surg Res. 1999, 82: 319-323. 10.1006\/jsre.1999.5580.","journal-title":"J Surg Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-5-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2474-5-41\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-5-41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-5-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:40:51Z","timestamp":1728304851000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-5-41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-5-41","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,12]]},"assertion":[{"value":"20 April 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}